Open access peer-reviewed chapter

Insulin-Like Growth Factor-II: Molecular-Targeted Therapy for Hepatocellular Carcinoma

By Min Yao, Li Wang, Meijuan Yan, Xiaodi Yan and Dengfu Yao

Submitted: April 30th 2012Reviewed: December 5th 2012Published: October 23rd 2013

DOI: 10.5772/55418

Downloaded: 944

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Min Yao, Li Wang, Meijuan Yan, Xiaodi Yan and Dengfu Yao (October 23rd 2013). Insulin-Like Growth Factor-II: Molecular-Targeted Therapy for Hepatocellular Carcinoma, Hepatocellular Carcinoma Ahmed Kaseb, IntechOpen, DOI: 10.5772/55418. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/hepatocellular-carcinoma-future-outlook/insulin-like-growth-factor-ii-molecular-targeted-therapy-for-hepatocellular-carcinoma" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

944total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Simultaneous Changes in Expression of Bile Canalicular CD10 and Sinusoidal CD105 (Endoglin) in Chronic Hepatitis and Liver Cirrhosis

By Toshitsugu Nakamura

Related Book

First chapter

Colorectal Cancer: It Starts and It Runs

By Rajunor Ettarh

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us